Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Cardiovasc Res

Retrieve available abstracts of 90 articles:
HTML format

Single Articles

    July 2022
  1. NYNS ECA, Jin T, Fontes MS, van den Heuvel T, et al
    Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.
    Cardiovasc Res. 2022;118:2293-2303.
    PubMed     Abstract available

  2. KEEFE J, Wehrens XH, Dobrev D
    Common disease-promoting signaling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences.
    Cardiovasc Res. 2022 Jul 5. pii: 6631397. doi: 10.1093.

    June 2022
  3. CHAUMONT C, Suffee N, Gandjbakhch E, Balse E, et al
    Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology.
    Cardiovasc Res. 2022;118:1693-1702.
    PubMed     Abstract available

  4. ALEXANDER C, Bishop MJ, Gilchrist RJ, MRes BA, et al
    Initiation of ventricular arrhythmia in the acquired long QT syndrome.
    Cardiovasc Res. 2022 Jun 21. pii: 6612700. doi: 10.1093.
    PubMed     Abstract available

  5. GAWALKO M, Saljic A, Li N, Abu-Taha I, et al
    Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance.
    Cardiovasc Res. 2022 Jun 11. pii: 6605797. doi: 10.1093.
    PubMed     Abstract available

    May 2022
  6. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
    The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Cardiovasc Res. 2022;118:1466-1478.
    PubMed     Abstract available

    April 2022
  7. LIUTKUTE A, Brundel BJ, Voigt N
    Not the classical serendipity: does doxapram treat atrial fibrillation?
    Cardiovasc Res. 2022 Apr 15. pii: 6568887. doi: 10.1093.

  8. FARINHA JM, Gupta D, Lip GYH
    Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation and stroke.
    Cardiovasc Res. 2022 Apr 7. pii: 6564589. doi: 10.1093.
    PubMed     Abstract available

    March 2022
  9. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    PubMed     Abstract available

  10. PROIETTI R, Lip GYH, Akhtar R, Field M, et al
    Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways.
    Cardiovasc Res. 2022;118:e32-e35.

  11. LOUCH WE
    A TRP to the emergency room: Understanding arrhythmia in the ageing heart.
    Cardiovasc Res. 2022;118:932-933.

  12. PEANA D, Polo-Parada L, Domeier TL
    Arrhythmogenesis in the aged heart following ischaemia-reperfusion: role of transient receptor potential vanilloid 4.
    Cardiovasc Res. 2022;118:1126-1137.
    PubMed     Abstract available

    January 2022
  13. MACIAS A, Diaz-Larrosa JJ, Blanco Y, Fanjul V, et al
    Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Cardiovasc Res. 2022;118:503-516.
    PubMed     Abstract available

  14. BARC J, Ravens U
    Scientists on the Spot: Tracing the potential in electrophysiology.
    Cardiovasc Res. 2022;118:e6-e7.

  15. JAYARAM R, Jones M, Reilly S, Crabtree MJ, et al
    Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin.
    Cardiovasc Res. 2022;118:184-195.
    PubMed     Abstract available

  16. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Publisher's note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2022 Jan 5. pii: 6498023. doi: 10.1093.

    December 2021
  17. RAVENS U, Gomez AM, Heijman J, Remme CA, et al
    Edward Carmeliet (1930-2021)-channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiologydagger.
    Cardiovasc Res. 2021;117:e171-e173.

  18. COPPINI R, Cerbai E
    Of hits, players, and goalkeepers: the case of arrhythmias in diabetes.
    Cardiovasc Res. 2021;117:2694-2695.

  19. HATEM SN, Cohen A
    Atrial fibrillation and stroke: are we looking in the right direction?
    Cardiovasc Res. 2021 Dec 13. pii: 6460256. doi: 10.1093.

    November 2021
  20. LI N, Durgan DJ, Wehrens XHT
    Gut microbiota - a key regulator of aging-associated atrial fibrillation?
    Cardiovasc Res. 2021 Nov 26. pii: 6443115. doi: 10.1093.
    PubMed     Abstract available

    October 2021
  21. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    PubMed     Abstract available

  22. NI L, Lahiri SK, Nie J, Pan X, et al
    Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice.
    Cardiovasc Res. 2021 Oct 14. pii: 6396865. doi: 10.1093.
    PubMed     Abstract available

    September 2021
  23. DOBREV D, Dudley SC
    Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?
    Cardiovasc Res. 2021;117:2291-2293.

  24. GAWALKO M, Agbaedeng TA, Saljic A, Muller DN, et al
    Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.
    Cardiovasc Res. 2021 Sep 22. pii: 6373888. doi: 10.1093.
    PubMed     Abstract available

    August 2021
  25. CAMPBELL H, Aguilar-Sanchez Y, Quick AP, Dobrev D, et al
    SPEG: a key regulator of cardiac calcium homeostasis.
    Cardiovasc Res. 2021;117:2175-2185.
    PubMed     Abstract available

  26. BALLOUZ S, Mangala MM, Perry MD, Heitmann S, et al
    Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
    Cardiovasc Res. 2021;117:2216-2227.
    PubMed     Abstract available

  27. DING WY, McDowell G, Lip GYH
    Utilising biomarkers in atrial fibrillation: the pros and cons.
    Cardiovasc Res. 2021 Aug 25. pii: 6357701. doi: 10.1093.

  28. POL T, Hijazi Z, Lindback J, Oldgren J, et al
    Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Aug 6. pii: 6343453. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  29. HALL EJ, Pal S, Glennon MS, Shridhar P, et al
    Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.
    Cardiovasc Res. 2021 Jul 30. pii: 6332002. doi: 10.1093.
    PubMed     Abstract available

  30. AL SAYED ZR, Canac R, Cimarosti B, Bonnard C, et al
    Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Cardiovasc Res. 2021;117:2092-2107.
    PubMed     Abstract available

  31. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    PubMed     Abstract available

  32. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.

  33. DERI S, Borbas J, Hartai T, Hategan L, et al
    Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
    Cardiovasc Res. 2021;117:1923-1934.
    PubMed     Abstract available

  34. RATHJENS FS, Blenkle A, Iyer LM, Renger A, et al
    Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
    Cardiovasc Res. 2021;117:1908-1922.
    PubMed     Abstract available

  35. ZHAO Y, James NA, Beshay AR, Chang EE, et al
    Adult zebrafish ventricular electrical gradients as tissue mechanisms of ECG patterns under baseline vs. oxidative stress.
    Cardiovasc Res. 2021;117:1891-1907.
    PubMed     Abstract available

    June 2021
    From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
    Cardiovasc Res. 2021;117:e88-e90.

  37. SCOTT L JR, Fender AC, Saljic A, Li L, et al
    NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.
    Cardiovasc Res. 2021;117:1746-1759.
    PubMed     Abstract available

  38. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    PubMed     Abstract available

  39. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2021;117:1-21.
    PubMed     Abstract available

  40. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    PubMed     Abstract available

  41. NATTEL S, Lip GYH, Filgueiras-Rama D, Dobrev D, et al
    Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation.
    Cardiovasc Res. 2021 Jun 4. pii: 6292088. doi: 10.1093.

    May 2021
  42. CASADEI B, Sipido KR
    Calcium and postoperative atrial fibrillation: round up the usual suspects!
    Cardiovasc Res. 2021 May 29. pii: 6288489. doi: 10.1093.

  43. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    PubMed     Abstract available

  44. HANNA P, Buch E, Stavrakis S, Meyer C, et al
    Neuroscientific Therapies for Atrial Fibrillation.
    Cardiovasc Res. 2021 May 14. pii: 6275748. doi: 10.1093.
    PubMed     Abstract available

  45. KANY S, Reissmann B, Metzner A, Kirchhof P, et al
    Genetics of atrial fibrillation - practical applications for clinical management: If not now, when and how?
    Cardiovasc Res. 2021 May 12. pii: 6274893. doi: 10.1093.
    PubMed     Abstract available

  46. OLIER I, Ortega-Martorell S, Pieroni M, Lip GYH, et al
    How machine learning is impacting research in atrial fibrillation: Implications for risk prediction and future management.
    Cardiovasc Res. 2021 May 12. pii: 6274894. doi: 10.1093.
    PubMed     Abstract available

    April 2021
  47. HEIJMAN J, Sutanto H, Crijns HJGM, Nattel S, et al
    Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care.
    Cardiovasc Res. 2021 Apr 23. pii: 6247759. doi: 10.1093.
    PubMed     Abstract available

  48. HATEM SN
    Revealing the molecular history of the transition from paroxysmal to permanent atrial fibrillation.
    Cardiovasc Res. 2021 Apr 20. pii: 6241493. doi: 10.1093.

    March 2021
  49. HERRAIZ-MARTINEZ A, Tarifa C, Jimenez-Sabado V, Llach A, et al
    Influence of sex on intracellular calcium homeostasis in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Mar 31. pii: 6206778. doi: 10.1093.
    PubMed     Abstract available

  50. NATTEL S, Sager P, Huser J, Heijman J, et al
    Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
    Cardiovasc Res. 2021 Mar 25. pii: 6189086. doi: 10.1093.
    PubMed     Abstract available

  51. ZHANG Y, Zhang S, Li B, Luo Y, et al
    Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome.
    Cardiovasc Res. 2021 Mar 23. pii: 6184135. doi: 10.1093.
    PubMed     Abstract available

  52. SAFABAKHSH S, Panwar P, Barichello S, Sangha SS, et al
    Cardiovasc Res. 2021 Mar 21. pii: 6179316. doi: 10.1093.
    PubMed     Abstract available

  53. QUINTANILLA JG, Shpun S, Jalife J, Filgueiras-Rama D, et al
    Novel approaches to mechanism-based atrial fibrillation ablation.
    Cardiovasc Res. 2021 Mar 21. pii: 6179319. doi: 10.1093.
    PubMed     Abstract available

  54. AGUILAR M, Rose RA, Takawale A, Nattel S, et al
    New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.
    Cardiovasc Res. 2021 Mar 16. pii: 6173397. doi: 10.1093.
    PubMed     Abstract available

  55. KORNEJ J, Hanger VA, Trinquart L, Ko D, et al
    New biomarkers from multiomics approaches - improving risk prediction of atrial fibrillation.
    Cardiovasc Res. 2021 Mar 5. pii: 6159768. doi: 10.1093.
    PubMed     Abstract available

    February 2021
  56. DITTMANN S, Kayser A, Schulze-Bahr E
    Long, longer, long QT syndrome: what makes the difference?
    Cardiovasc Res. 2021;117:637-639.

  57. PROTONOTARIOS A, Marelli-Berg F
    Influenza-associated cardiac injury: a disease of the cardiac conduction system?
    Cardiovasc Res. 2021;117:643-644.

  58. LEE YK, Sala L, Mura M, Rocchetti M, et al
    MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
    Cardiovasc Res. 2021;117:767-779.
    PubMed     Abstract available

  59. LI X, Garcia-Elias A, Benito B, Nattel S, et al
    The effects of cardiac stretch on atrial fibroblasts: Analysis of the evidence and potential role in atrial fibrillation.
    Cardiovasc Res. 2021 Feb 10. pii: 6133258. doi: 10.1093.
    PubMed     Abstract available

  60. NIETO-MARIN P, Tinaquero D, Utrilla RG, Cebrian J, et al
    Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
    Cardiovasc Res. 2021 Feb 8. pii: 6130792. doi: 10.1093.
    PubMed     Abstract available

    January 2021
  61. MIGHIU AS, Recalde A, Ziberna K, Carnicer R, et al
    Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.
    Cardiovasc Res. 2021 Jan 23. pii: 6105183. doi: 10.1093.
    PubMed     Abstract available

  62. DING WY, Protty MB, Davies IG, Lip GYH, et al
    Relationship between lipoproteins, thrombosis and atrial fibrillation.
    Cardiovasc Res. 2021 Jan 23. pii: 6111888. doi: 10.1093.
    PubMed     Abstract available

  63. HEGYI B, Ko CY, Bossuyt J, Bers DM, et al
    Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycemia: reduced repolarization reserve, neurohormonal stimulation and heart failure exacerbate susceptibility.
    Cardiovasc Res. 2021 Jan 23. pii: 6105172. doi: 10.1093.
    PubMed     Abstract available

  64. TOENNIS T, Kirchhof P
    Connecting the dots? Rate control, heart failure, and atrial fibrillation.
    Cardiovasc Res. 2021;117:336-337.

  65. RONCHI C, Bernardi J, Mura M, Stefanello M, et al
    NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Cardiovasc Res. 2021;117:472-483.
    PubMed     Abstract available

  66. GUICHARD JB, Xiong F, Qi XY, L'Heureux N, et al
    Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodelling.
    Cardiovasc Res. 2021;117:462-471.
    PubMed     Abstract available

  67. CASADEI B, Wijesurendra R
    Atrial fibrillation after cardiac surgery: to screen or not to screen?
    Cardiovasc Res. 2021 Jan 12. pii: 6091151. doi: 10.1093.

  68. BENZ AP, Healey JS, Chin A, Commerford P, et al
    Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
    Cardiovasc Res. 2021 Jan 2. pii: 6059218. doi: 10.1093.
    PubMed     Abstract available

    November 2020
  69. BENTLEY R, Logantha SJRJ, Sharma P, Rainbow RR, et al
    Pathophysiological insights into atrial fibrillation: revisiting electrophysiological substrate, anatomical substrate, and possible insights from proteomics.
    Cardiovasc Res. 2020 Nov 18. pii: 5989794. doi: 10.1093.

  70. VITOLO M, Lip GYH
    Understanding the global burden of atrial fibrillation and regional variations: we need improvement.
    Cardiovasc Res. 2020 Nov 11. pii: 5974204. doi: 10.1093.

    Two sides of the same coin: new insights into mechanisms of ventricular fibrillation.
    Cardiovasc Res. 2020 Nov 6. pii: 5957449. doi: 10.1093.

  72. SCHMIDT C, Bollini S
    ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow.
    Cardiovasc Res. 2020;116:e190-e192.

    October 2020
  73. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2020 Oct 29. pii: 5942974. doi: 10.1093.
    PubMed     Abstract available

  74. FAKUADE FE, Tomsits P, Voigt N
    Connexin hemichannels in atrial fibrillation - Orphaned and irrelevant?
    Cardiovasc Res. 2020 Oct 28. pii: 5942088. doi: 10.1093.

    September 2020
  75. DING WY, Gupta D, Wong CF, Lip GYH, et al
    Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease.
    Cardiovasc Res. 2020 Sep 1. pii: 5900260. doi: 10.1093.
    PubMed     Abstract available

    August 2020
  76. JOSEPH PG, Healey JS, Raina P, Connolly SJ, et al
    Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153,152 middle-aged individuals.
    Cardiovasc Res. 2020 Aug 10. pii: 5890677. doi: 10.1093.
    PubMed     Abstract available

    July 2020
  77. SCHMIDT C, Ravens U
    Genetic background of atrial fibrillation: influence of single-nucleotide polymorphisms.
    Cardiovasc Res. 2020;116:e106-e108.

  78. PERRY MD, Ng CA, Mangala MM, Ng TYM, et al
    Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
    Cardiovasc Res. 2020;116:1434-1445.
    PubMed     Abstract available

  79. LEMME M, Braren I, Prondzynski M, Aksehirlioglu B, et al
    Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.
    Cardiovasc Res. 2020;116:1487-1499.
    PubMed     Abstract available

  80. SURYAWANSHI H, Clancy R, Morozov P, Halushka MK, et al
    Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block.
    Cardiovasc Res. 2020;116:1446-1457.
    PubMed     Abstract available

    June 2020
  81. TIEU A, Akar FG
    'Social distancing' of the neuronal nitric oxide synthase from its adaptor protein causes arrhythmogenic trigger-substrate interactions in Long QT Syndrome.
    Cardiovasc Res. 2020 Jun 26. pii: 5863265. doi: 10.1093.

  82. ZHANG Y, Qi Y, Li JJ, He WJ, et al
    Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts.
    Cardiovasc Res. 2020 Jun 12. pii: 5856737. doi: 10.1093.
    PubMed     Abstract available

  83. FAKUADE FE, Steckmeister V, Seibertz F, Gronwald J, et al
    Altered Atrial Cytosolic Calcium Handling Contributes to the Development of Postoperative Atrial Fibrillation.
    Cardiovasc Res. 2020 Jun 10. pii: 5855672. doi: 10.1093.
    PubMed     Abstract available

    May 2020
  84. HANDA BS, Li X, Baxan N, Roney C, et al
    Ventricular fibrillation mechanism and global fibrillatory organisation are determined by gap junction coupling and fibrosis pattern.
    Cardiovasc Res. 2020 May 13. pii: 5836828. doi: 10.1093.
    PubMed     Abstract available

  85. CHEEDIPUDI SM, Hu J, Fan S, Yuan P, et al
    Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cardiovasc Res. 2020;116:1199-1213.
    PubMed     Abstract available

    March 2020
  86. TSAI SY, Ghazizadeh Z, Wang HJ, Amin S, et al
    A human embryonic stem cell reporter line for monitoring chemical-induced cardiotoxicity.
    Cardiovasc Res. 2020;116:658-670.
    PubMed     Abstract available

    January 2020
  87. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    PubMed     Abstract available

  88. PATEL J, Bezzina CR
    Scientists on the Spot: The complex inheritance of cardiac disorders.
    Cardiovasc Res. 2020;116:e11.

    March 2019
  89. DIETRICHS ES, Tveita T, Smith G
    Hypothermia and cardiac electrophysiology: a systematic review of clinical and experimental data.
    Cardiovasc Res. 2019;115:501-509.
    PubMed     Abstract available

  90. VALVERDE CA, Mazzocchi G, Di Carlo MN, Ciocci Pardo A, et al
    Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Cardiovasc Res. 2019;115:556-569.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.